Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beswick

Showing results (601-610 of 673) with videos related to

Pageof 68
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 13, 2011
Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitorRobert J Young, Wendy Alderton, Anthony D R Angell, et al.
Communications Biology|May 18, 2023
Identification of acquired Notch3 dependency in metastatic Head and Neck CancerMaria Kondratyev, Aleksandra Pesic, Troy Ketela, et al.
International Forum of Allergy & Rhinology|December 29, 2022
Management paradigms for chronic rhinosinusitis in individuals with asthma: An evidence-based review with recommendationsAmarbir S Gill, Jeremiah A Alt, Kara Y Detwiller, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2010
Synthesis and structure-activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptorLaura J Chambers, Alexander J Stevens, Andrew P Moses, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 14, 2026
Psychometric validity of the 22-item sinonasal outcome test in cystic fibrosisChristine M Liu, Jakob L Fischer, Jonathan B Overdevest, et al.
Plos One|December 3, 2010
Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitorsOliver N F King, Xuan Shirley Li, Masaaki Sakurai, et al.
Molecular Cancer Therapeutics|September 16, 2022
BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid TumorsMichael Rigby, Gavin Bennett, Liuhong Chen, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
Identification of 2-oxo-N-(phenylmethyl)-4-imidazolidinecarboxamide antagonists of the P2X(7) receptorLee Abberley, Aude Bebius, Paul J Beswick, et al.
JCI Insight|November 10, 2025
Transcriptomic and functional responses of the cystic fibrosis airway epithelium to CFTR modulator therapyEszter K Vladar, Austin E Gillen, Sangya Yadav, et al.
Cancers|March 11, 2023
Health-Related Quality of Life as Assessed by the EQ-5D-5L Predicts Outcomes of Patients Treated with Azacitidine-A Prospective Cohort Study by the AGMTLisa Pleyer, Sonja Heibl, Christoph Tinchon, et al.
Pageof 68

Showing results (601-610 of 673) with videos related to

Sort By:
Pageof 68
Bioorganic & Medicinal Chemistry Letters|April 13, 2011
Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitorRobert J Young, Wendy Alderton, Anthony D R Angell, et al.
Communications Biology|May 18, 2023
Identification of acquired Notch3 dependency in metastatic Head and Neck CancerMaria Kondratyev, Aleksandra Pesic, Troy Ketela, et al.
International Forum of Allergy & Rhinology|December 29, 2022
Management paradigms for chronic rhinosinusitis in individuals with asthma: An evidence-based review with recommendationsAmarbir S Gill, Jeremiah A Alt, Kara Y Detwiller, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2010
Synthesis and structure-activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptorLaura J Chambers, Alexander J Stevens, Andrew P Moses, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 14, 2026
Psychometric validity of the 22-item sinonasal outcome test in cystic fibrosisChristine M Liu, Jakob L Fischer, Jonathan B Overdevest, et al.
Plos One|December 3, 2010
Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitorsOliver N F King, Xuan Shirley Li, Masaaki Sakurai, et al.
Molecular Cancer Therapeutics|September 16, 2022
BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid TumorsMichael Rigby, Gavin Bennett, Liuhong Chen, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
Identification of 2-oxo-N-(phenylmethyl)-4-imidazolidinecarboxamide antagonists of the P2X(7) receptorLee Abberley, Aude Bebius, Paul J Beswick, et al.
JCI Insight|November 10, 2025
Transcriptomic and functional responses of the cystic fibrosis airway epithelium to CFTR modulator therapyEszter K Vladar, Austin E Gillen, Sangya Yadav, et al.
Cancers|March 11, 2023
Health-Related Quality of Life as Assessed by the EQ-5D-5L Predicts Outcomes of Patients Treated with Azacitidine-A Prospective Cohort Study by the AGMTLisa Pleyer, Sonja Heibl, Christoph Tinchon, et al.
Pageof 68